ARCHIVES

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 21 No. 33 | August 18, 1995

Download PDF Visit The Full Archive

Related Articles

NCI By Pass Budget For FY 1987 Is $1.57 Bil.

October 18, 1985

Book Offers Info For Women Considering Ovary Removal

November 24, 2006

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

Obituary: Edwin Fisher, NSABP Pathologist.

April 4, 2008

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson In U.S. News & World Report Ranking

July 18, 2014

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998